Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 461
interventional 375
Observational 83
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 208
Device 35
Drug|Procedure 31
Drug|placebo 20
Drug|Other 19
Procedure 15
Other 9
Biological 8
Biological|placebo 4
Device|Drug 4
Biological|Procedure 3
Device|Other 3
Combination Product 2
Diagnostic Test 2
Dietary Supplement|placebo 2
Drug|Other|placebo 2
Behavioral 1
Biological|Device|Diagnostic Test 1
Biological|Drug 1
Biological|Other 1
Biological|Radiation 1
Combination Product|Device 1
Combination Product|Procedure 1
Device|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 133
NA 35
China 15
Canada 14
Japan 12
Brazil 10
France 9
Korea, Republic of 9
Australia 7
Germany 7
Mexico 7
United Kingdom 7
Turkey 6
Denmark 4
Egypt 4
India 4
Iran, Islamic Republic of 4
Israel 4
Spain 4
Switzerland 4
Taiwan 4
Austria 3
Italy 3
United States|Canada 3
Malaysia 2
Norway 2
Argentina|Mexico 1
Australia|Austria|Czech Republic|Denmark|France|Germany|Hungary|Italy|Japan|Poland|Spain|Taiwan 1
Australia|Belgium|Canada|Czech Republic|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Latvia|Netherlands|Russian Federation|Singapore|Slovakia|Spain|Switzerland|Turkey|United Kingdom 1
Australia|Belgium|Canada|France|Germany|Greece|Hungary|Italy|Netherlands|Spain|Switzerland|Turkey|United Kingdom 1
Austria|Australia|Canada|Czech Republic|Denmark|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Austria|Belgium|Germany|Hungary|Netherlands|Portugal|Spain 1
Austria|Canada|Czechia|France|Germany|Hungary|Italy|Lithuania|Poland|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Belgium 1
Belgium|Czech Republic|France|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
Belgium|France|Germany|Greece|Hungary|Portugal|Spain|United Kingdom 1
Belgium|France|Germany|Slovakia|Spain|Switzerland|United Kingdom 1
Belgium|Germany|Italy|Netherlands|Spain|United Kingdom 1
Bulgaria|Belgium|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Korea, Republic of|Latvia|Lebanon|Lithuania|Malaysia|Norway|Poland|Russian Federation|Singapore|Slovakia|Sweden|Switzerland|Taiwan|Turkey 1
Bulgaria|Czech Republic|Denmark|Germany|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
China|Hong Kong|Indonesia|Philippines|Taiwan|Vietnam 1
China|Hong Kong|Japan|Korea, Republic of|Singapore|Taiwan 1
China|Hong Kong|Korea, Republic of|Russian Federation 1
China|India 1
China|Philippines 1
Croatia 1
Cuba 1
Czech Republic|Germany|Hungary|Poland|United Kingdom 1
Czechia|Hungary|Slovakia 1
Finland|Spain|Sweden|United Kingdom 1
Germany|Austria|Canada|Czechia|France|Hungary|Italy|Lithuania|Poland|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Germany|Hungary|Poland|United Kingdom 1
Germany|United States|Australia|Belgium|Brazil|Canada|China|Croatia|Czechia|Denmark|Finland|France|Hungary|Israel|Italy|Japan|Korea, Republic of|Lithuania|Portugal|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
Hungary|United States|Austria|Bulgaria|France|Germany|Israel|Italy|Japan|Mexico|Peru|Poland|Russian Federation|Slovakia|Spain|Turkey 1
Indonesia 1
Israel|Poland 1
Israel|United States|Australia|Latvia 1
Italy|United States|Argentina|Australia|Austria|Canada|Colombia|Israel|Japan|Netherlands|Portugal|Puerto Rico|Spain|United Kingdom 1
Japan|Korea, Republic of 1
Kuwait 1
Portugal 1
Portugal|Spain 1
Singapore 1
Slovakia|United States|Hungary|Israel|Puerto Rico 1
Switzerland|United States|Argentina|Australia|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Poland|Portugal|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Brazil|Canada|Colombia|Czechia|Denmark|France|Germany|Greece|India|Italy|Netherlands|Portugal|South Africa|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Czechia|France|Germany|Israel|Mexico|Philippines|Portugal|South Africa|Taiwan 1
United States|Australia|Belgium|Czech Republic|France|Germany|Israel|Italy|Poland|Spain 1
United States|Australia|Canada|Czech Republic|Germany|Israel|Philippines|Portugal|South Africa|Spain 1
United States|Australia|Canada|Germany|Netherlands|United Kingdom 1
United States|Australia|Canada|India|United Kingdom 1
United States|Australia|Canada|Israel|South Africa 1
United States|Australia|Canada|United Kingdom 1
United States|Belgium|Czech Republic|Germany|Israel|Poland|United Kingdom 1
United States|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Portugal|South Africa|Spain|United Kingdom 1
United States|Brazil|Canada|Colombia|France|Hungary|India|Italy|Korea, Republic of|New Zealand|Poland|Singapore|Taiwan|United Kingdom 1
United States|Brazil|Canada|Colombia|Hong Kong|India|Italy|Korea, Republic of|New Zealand|Poland|Singapore|Spain|United Kingdom 1
United States|Canada|Colombia|India|Israel 1
United States|Canada|Denmark|Germany|Lithuania|Mexico|Portugal|Romania|Spain|United Kingdom 1
United States|Czechia|Germany|Hungary|India|Japan|Latvia|Poland|Russian Federation 1
United States|Germany|Puerto Rico|Spain 1
United States|Korea, Republic of 1
United States|Puerto Rico 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 210
2 27
3 10
4 14
5 7
6 6
7 6
8 3
9 1
10 3
11 3
12 3
13 7
14 3
15 4
16 3
17 2
18 4
20 6
21 2
25 2
26 2
28 1
29 1
30 1
32 1
33 2
34 1
35 3
37 1
39 1
41 1
42 2
43 2
50 2
51 3
56 1
61 2
64 2
65 1
66 1
68 1
73 1
76 3
78 1
80 1
84 1
90 2
95 1
99 1
103 1
106 1
123 1
187 1
196 1
244 1

Phase

Phase Study_Count
Phase 3 88
N/A 72
Phase 2 72
Phase 4 64
Phase 1 33
Phase 1/Phase 2 28
Phase 2/Phase 3 15
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 85
2 163
3 72
4 14
5 3
6 2
7 3
8 4
9 1
11 1
NA 27

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 5.00000 3.00 6.00000 3.00 18.00000 5.0000 7.00000
1st Qu. 10.0 26.50000 6.00 20.00000 40.75 35.00000 101.7500 30.50000
Median 10.0 45.50000 14.50 29.50000 70.50 58.00000 272.5000 50.00000
Mean 15.0 84.11111 27.00 44.30769 101.60 83.92308 337.5581 89.25397
3rd Qu. 17.5 84.00000 40.25 48.50000 130.50 74.00000 465.2500 109.50000
Max. 25.0 608.00000 108.00 153.00000 375.00 317.00000 1260.0000 560.00000

Trial Group Type

group_type Group_Count
Experimental 421
Active Comparator 245
Placebo Comparator 43
Sham Comparator 39
NA 27
Other 21
No Intervention 14

Intervention Model

intervention_model Study_Count
Parallel Assignment 236
Single Group Assignment 112
Crossover Assignment 10
NA 9
Sequential Assignment 6
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 326
Prevention 19
Diagnostic 8
Basic Science 6
Supportive Care 5
NA 5
Other 4
Device Feasibility 1
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 21
Germany 9
United Kingdom 7
France 6
NA 5
Canada 4
China 3
Mexico 3
Austria 2
Portugal 2
Switzerland 2
Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Costa Rica|Czech Republic|Dominican Republic|Ecuador|Egypt|France|Germany|Greece|Guatemala|Hong Kong|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Panama|Peru|Poland|Portugal|Russian Federation|Saudi Arabia|Singapore|Slovakia|Slovenia|Spain|Turkey|Ukraine|United Kingdom|Venezuela 1
Australia 1
Belgium 1
Brazil 1
China|Egypt|France|Germany|Italy|Kuwait|Lebanon|Russian Federation|Saudi Arabia|Taiwan|United Arab Emirates 1
Egypt 1
Finland|France|Israel|Italy|Portugal|Spain|Sweden|United Kingdom 1
France|Germany|Greece|Portugal|Russian Federation|Slovakia|Spain|United Kingdom 1
Indonesia 1
Israel 1
Italy 1
Japan 1
Netherlands 1
Poland 1
Romania 1
Russian Federation 1
Thailand 1
Turkey 1
United Arab Emirates 1

Sites per Study

Site_count Study_Count
1 66
2 3
4 2
5 1
6 2
7 1
8 1
11 1
18 1
23 1
25 2
48 1
463 1

Enrollment Metrics

Measure Observational
Min 3.0000
1st Qu 30.2500
Median 51.5000
Mean 542.5366
3rd Qu 131.5000
Max 30490.0000

Observation Model

observational_model Study_Count
Cohort 45
Case-Only 20
Other 7
Case-Control 5
Case-Crossover 2
Case Control 2
Ecologic or Community 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 59
Retrospective 17
Cross-Sectional 3
Other 3
NA 1

Registries

Studies by Country

Country Study_Count
Germany 1
Mexico 1
Pakistan 1

Sites per Study

Site_count Study_Count
1 3

Enrollment Metrics

Measure Registries
Min 60
1st Qu 80
Median 100
Mean 3228
3rd Qu 4812
Max 9524

Registry Model

observational_model Study_Count
Case-Only 1
Case Control 1
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 2
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Day 2
12 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT02638350 Performance Evaluation of Clinical Ultrasound in Management of Acute Pulmonary Edema in Elderly Patient https://ClinicalTrials.gov/show/NCT02638350 Completed University Hospital, Toulouse 2019-03-21
NCT02571972 Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. https://ClinicalTrials.gov/show/NCT02571972 Completed Wills Eye 2015-09-30
NCT02348918 Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02348918 Completed Allegro Ophthalmics, LLC 2017-05-16
NCT03386019 The Efficacy of Lymphatic Massage on Lower Extremity Edema and Performance After Treadmill Exercise in Sprinter Compare to Static Stretching and Cold Water Immersion https://ClinicalTrials.gov/show/NCT03386019 Completed National Taiwan University Hospital 2017-11-28
NCT03405376 Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03405376 Recruiting Yeungnam University College of Medicine 2019-03-31
NCT01651156 Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema https://ClinicalTrials.gov/show/NCT01651156 Completed Otsuka Beijing Research Institute 2013-07-31
NCT01120899 A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01120899 Completed National Institutes of Health Clinical Center (CC) 2011-08-31
NCT03341676 Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) https://ClinicalTrials.gov/show/NCT03341676 Recruiting University Hospitals Coventry and Warwickshire NHS Trust 2020-03-04
NCT03329989 Safety and Effectiveness of EN3835 in the Treatment of EFP in Women https://ClinicalTrials.gov/show/NCT03329989 Completed Endo Pharmaceuticals 2018-09-05
NCT03328715 iOCT for Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03328715 Recruiting Vienna Institute for Research in Ocular Surgery 2020-09-01
NCT03323580 Effects of Intraoperative GDFT on the Postoperative Brain Edema https://ClinicalTrials.gov/show/NCT03323580 Recruiting Beijing Tiantan Hospital 2022-10-31
NCT03321513 DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME https://ClinicalTrials.gov/show/NCT03321513 Active, not recruiting Jaeb Center for Health Research 2021-12-20
NCT03211741 Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema https://ClinicalTrials.gov/show/NCT03211741 Recruiting University Hospital, Ghent 2021-01-01
NCT03197480 Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME https://ClinicalTrials.gov/show/NCT03197480 Recruiting Singapore National Eye Centre 2020-12-31
NCT03179813 Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery https://ClinicalTrials.gov/show/NCT03179813 Completed University of Sao Paulo 2018-01-03
NCT03161652 Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03161652 Recruiting Universidad Nacional Autonoma de Mexico 2022-05-31
NCT03143192 Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser https://ClinicalTrials.gov/show/NCT03143192 Completed Toronto Retina Institute 2019-05-09
NCT03126786 Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03126786 Completed Clearside Biomedical, Inc. 2018-04-17
NCT03108352 Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03108352 Recruiting Chengdu Kanghong Biotech Co., Ltd. 2019-12-31
NCT02308644 Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study https://ClinicalTrials.gov/show/NCT02308644 Completed University of Sao Paulo 2011-12-31
NCT03093701 TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT03093701 Active, not recruiting Taiwan Liposome Company 2020-12-31
NCT03079453 An Approach to Reduce Uvula Edema After Tonsillectomy https://ClinicalTrials.gov/show/NCT03079453 Completed Bezmialem Vakif University 2019-04-01
NCT03071068 A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03071068 Completed ThromboGenics 2018-04-30
NCT03069521 Study to Evaluate the Safety of the EndoArtâ„¢ for Treatment of Subjects Suffering From Corneal Edema https://ClinicalTrials.gov/show/NCT03069521 Recruiting Eye-yon Medical 2019-12-31
NCT03056092 Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab https://ClinicalTrials.gov/show/NCT03056092 Recruiting St. Michael’s Hospital, Toronto 2020-02-28
NCT03056079 Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept https://ClinicalTrials.gov/show/NCT03056079 Recruiting St. Michael’s Hospital, Toronto 2020-02-28
NCT02262260 Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME https://ClinicalTrials.gov/show/NCT02262260 Completed Novartis 2017-09-12
NCT03000283 Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study https://ClinicalTrials.gov/show/NCT03000283 Completed Allina Health System 2019-02-12
NCT02985619 Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02985619 Completed University of Sao Paulo 2017-04-14
NCT02977572 Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT02977572 Completed Hospital General Universitario de Castellón 2010-12-31
NCT02953938 Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety https://ClinicalTrials.gov/show/NCT02953938 Completed Novartis 2018-12-28
NCT02949024 Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02949024 Completed Clearside Biomedical, Inc. 2017-04-12
NCT02942160 EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) https://ClinicalTrials.gov/show/NCT02942160 Completed Endo Pharmaceuticals 2018-06-14
NCT02914613 Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02914613 Completed SciFluor Life Sciences, Inc. 2017-05-16
NCT02901379 Effect of 80-mg Atorvastatin on Myocardial Edema https://ClinicalTrials.gov/show/NCT02901379 Completed National Cardiovascular Center Harapan Kita Hospital Indonesia 2018-08-31
NCT02867735 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema https://ClinicalTrials.gov/show/NCT02867735 Completed Novartis 2018-02-15
NCT02864953 Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction https://ClinicalTrials.gov/show/NCT02864953 Recruiting Biogen 2021-03-31
NCT02856698 MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial) https://ClinicalTrials.gov/show/NCT02856698 Recruiting Hospital Universitario de Canarias 2020-12-31
NCT01529385 Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes https://ClinicalTrials.gov/show/NCT01529385 Completed Rosalind Franklin University of Medicine and Science 2014-09-30
NCT02818998 Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02818998 Completed Bayer 2018-11-13
NCT02796183 The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02796183 Completed Neon Hospital 2016-04-30
NCT02788877 Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) https://ClinicalTrials.gov/show/NCT02788877 Active, not recruiting Pusan National University Hospital 2019-09-30
NCT01486238 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study https://ClinicalTrials.gov/show/NCT01486238 Completed Valley Retina Institute 2011-07-31
NCT01472510 Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy https://ClinicalTrials.gov/show/NCT01472510 Completed Vitreo-Retinal Associates, PC 2013-07-31
NCT02734407 Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02734407 Completed Retina-Vitreous Associates Medical Group 2017-09-27
NCT02732951 Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02732951 Completed Boehringer Ingelheim 2017-10-23
NCT02724644 EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) https://ClinicalTrials.gov/show/NCT02724644 Completed Endo Pharmaceuticals 2016-09-30
NCT02712008 Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02712008 Completed Regeneron Pharmaceuticals 2017-07-10
NCT02698566 A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) https://ClinicalTrials.gov/show/NCT02698566 Completed Genentech, Inc. 2016-04-05
NCT02663141 Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02663141 Completed Tehran University of Medical Sciences 2016-06-30
NCT02660151 Study of Using the Hyper-CLâ„¢ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema https://ClinicalTrials.gov/show/NCT02660151 Completed Eye-yon Medical 2018-10-31
NCT02633852 Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02633852 Completed Hadassah Medical Organization 2018-08-28
NCT02627976 Breast Edema Compression Vest https://ClinicalTrials.gov/show/NCT02627976 Completed UMC Utrecht 2018-01-31
NCT02626585 The Effect of Postrhinoplasty Taping on Postoperative Edema and Nasal Draping https://ClinicalTrials.gov/show/NCT02626585 Completed Bezmialem Vakif University 2015-06-30
NCT02624765 FAST Therapy Trial of Fetal Tachyarrhythmia https://ClinicalTrials.gov/show/NCT02624765 Recruiting The Hospital for Sick Children 2021-03-31
NCT02623426 Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial https://ClinicalTrials.gov/show/NCT02623426 Active, not recruiting JHSPH Center for Clinical Trials 2021-01-31
NCT02614937 Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT02614937 Completed Ohr Pharmaceutical Inc. 2014-12-31
NCT02609165 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT02609165 Completed Ospedale San Raffaele 2017-02-28
NCT02559180 Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab https://ClinicalTrials.gov/show/NCT02559180 Recruiting The Cleveland Clinic 2020-11-30
NCT02556723 Intravitreal Injections of Ziv-aflibercept for Macular Diseases https://ClinicalTrials.gov/show/NCT02556723 Completed Retina Clinic, Sao Paulo, Brazil 2015-09-30
NCT03397264 A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03397264 Active, not recruiting Opthea Limited 2020-05-31
NCT02554747 Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa https://ClinicalTrials.gov/show/NCT02554747 Completed Odense University Hospital 2017-12-31
NCT02503540 Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO https://ClinicalTrials.gov/show/NCT02503540 Completed The Cleveland Clinic 2018-02-06
NCT02472366 A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy https://ClinicalTrials.gov/show/NCT02472366 Completed Alimera Sciences 2015-03-31
NCT02471651 Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02471651 Completed California Retina Consultants 2018-10-24
NCT02457884 Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02457884 Completed The Hong Kong Polytechnic University 2018-03-31
NCT02448446 The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates https://ClinicalTrials.gov/show/NCT02448446 Completed South Coast Retina Center; Carson, McBeath, Boswell, Inc. 2018-05-31
NCT02443012 Topical Nepafenac as Supplement for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02443012 Completed Universiti Sains Malaysia 2014-08-31
NCT02441907 Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02441907 Completed St. Michael’s Hospital, Toronto 2018-08-31
NCT02427880 Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema https://ClinicalTrials.gov/show/NCT02427880 Completed Shiraz University of Medical Sciences 2015-06-30
NCT02406157 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02406157 Completed Sun Yat-sen University 2018-07-31
NCT02403128 Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms https://ClinicalTrials.gov/show/NCT02403128 Active, not recruiting Illinois Retina and Eye Associates 2020-02-29
NCT02392364 Variable Interval Versus Set Interval Aflibercept for DME https://ClinicalTrials.gov/show/NCT02392364 Completed California Retina Consultants 2018-11-15
NCT02374060 PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial https://ClinicalTrials.gov/show/NCT02374060 Completed JHSPH Center for Clinical Trials 2017-08-30
NCT01613716 Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) https://ClinicalTrials.gov/show/NCT01613716 Completed The Cleveland Clinic 2016-12-31
NCT01627249 Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01627249 Completed Jaeb Center for Health Research 2014-10-31
NCT02359526 A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients https://ClinicalTrials.gov/show/NCT02359526 Completed Association for Innovation and Biomedical Research on Light and Image 2016-03-31
NCT02316210 Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema https://ClinicalTrials.gov/show/NCT02316210 Completed Firstkind Ltd 2015-09-30
NCT02314299 A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration https://ClinicalTrials.gov/show/NCT02314299 Completed Stealth BioTherapeutics Inc. 2015-05-31
NCT02310295 Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02310295 Completed University of Sao Paulo 2011-12-31
NCT02303184 Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO https://ClinicalTrials.gov/show/NCT02303184 Completed Clearside Biomedical, Inc. 2016-03-31
NCT02294656 Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide https://ClinicalTrials.gov/show/NCT02294656 Completed Soll Eye 2018-09-30
NCT02259088 A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients https://ClinicalTrials.gov/show/NCT02259088 Completed Novartis 2017-01-17
NCT02255032 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis https://ClinicalTrials.gov/show/NCT02255032 Completed Clearside Biomedical, Inc. 2015-12-31
NCT02245516 Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02245516 Completed Kala Pharmaceuticals, Inc. 2014-12-31
NCT02221453 Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide https://ClinicalTrials.gov/show/NCT02221453 Completed St. Michael’s Hospital, Toronto 2016-12-31
NCT02193113 A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME https://ClinicalTrials.gov/show/NCT02193113 Completed KalVista Pharmaceuticals, Ltd. 2015-06-04
NCT02186119 A Study of Abicipar Pegol in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02186119 Completed Allergan 2015-06-30
NCT02131350 Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema https://ClinicalTrials.gov/show/NCT02131350 Completed Shinshu University 2017-03-31
NCT02121262 A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02121262 Completed Allergan 2019-10-09
NCT02103283 A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02103283 Completed River Vision Development Corporation 2016-08-31
NCT02084576 Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification https://ClinicalTrials.gov/show/NCT02084576 Completed Hospital Oftalmologico de Brasilia 2013-08-31
NCT03973138 Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab https://ClinicalTrials.gov/show/NCT03973138 Recruiting Sun Yat-sen University 2020-01-01
NCT01348269 Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome https://ClinicalTrials.gov/show/NCT01348269 Completed Wuerzburg University Hospital 2015-08-26
NCT01315275 A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema https://ClinicalTrials.gov/show/NCT01315275 Completed Novartis 2012-08-31
NCT01309451 Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01309451 Completed Maturi, Raj K., M.D., P.C. 2013-04-30
NCT01304706 Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study https://ClinicalTrials.gov/show/NCT01304706 Completed Alimera Sciences 2013-11-30
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01298076 Completed University of Sydney 2014-09-30
NCT01297569 Ranibizumab “Treat and Extend” in Diabetic Macular Edma https://ClinicalTrials.gov/show/NCT01297569 Completed Novartis 2012-11-30
NCT01292798 Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab https://ClinicalTrials.gov/show/NCT01292798 Completed California Retina Consultants 2013-04-30
NCT01284478 Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery https://ClinicalTrials.gov/show/NCT01284478 Completed Northern California Retina Vitreous Associates 2012-10-31
NCT01277302 A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01277302 Completed Genentech, Inc. 2012-10-31
NCT02055872 Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02055872 Completed Hamilton Health Sciences Corporation 2016-10-31
NCT02050828 The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02050828 Completed Aerpio Therapeutics 2015-04-30
NCT02036424 Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02036424 Completed Maturi, Raj K., M.D., P.C. 2015-08-31
NCT02006147 Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO https://ClinicalTrials.gov/show/NCT02006147 Active, not recruiting Taiwan Liposome Company 2020-12-31
NCT02002403 Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02002403 Completed St. Michael’s Hospital, Toronto 2012-04-30
NCT01997164 Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (“Wet”) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01997164 Completed Regeneron Pharmaceuticals 2015-10-31
NCT01987986 A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy https://ClinicalTrials.gov/show/NCT01987986 Completed Endo Pharmaceuticals 2014-08-31
NCT01982435 Safety and Efficacy of Ranibizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01982435 Completed The Cleveland Clinic 2016-05-26
NCT01976338 Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) https://ClinicalTrials.gov/show/NCT01976338 Completed Novartis 2016-03-28
NCT01939691 Macular Edema Nepafenac vs. Difluprednate Uveitis Trial https://ClinicalTrials.gov/show/NCT01939691 Recruiting University of California, San Francisco 2020-11-30
NCT01934556 A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01934556 Completed Palmetto Retina Center, LLC 2017-04-30
NCT01909791 Treatment for CI-DME in Eyes With Very Good VA Study https://ClinicalTrials.gov/show/NCT01909791 Completed Jaeb Center for Health Research 2018-09-11
NCT01903720 A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01903720 Completed Allergan 2014-09-24
NCT01892163 Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone https://ClinicalTrials.gov/show/NCT01892163 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-12-31
NCT01887379 Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) https://ClinicalTrials.gov/show/NCT01887379 Completed LTS Lohmann Therapie-Systeme AG 2013-08-31
NCT01875783 OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits https://ClinicalTrials.gov/show/NCT01875783 Completed Joslin Diabetes Center 2015-05-14
NCT01870440 TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema https://ClinicalTrials.gov/show/NCT01870440 Completed Northern California Retina Vitreous Associates 2015-02-28
NCT01870427 NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions https://ClinicalTrials.gov/show/NCT01870427 Completed Northern California Retina Vitreous Associates 2015-08-31
NCT01860820 The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema https://ClinicalTrials.gov/show/NCT01860820 Enrolling by invitation Lawson Health Research Institute 2019-09-30
NCT01823965 Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment https://ClinicalTrials.gov/show/NCT01823965 Completed Poitiers University Hospital 2014-07-31
NCT01821677 AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01821677 Completed Ampio Pharmaceuticals. Inc. 2014-06-30
NCT01823081 Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01823081 Completed Shahid Beheshti University of Medical Sciences 2013-06-30
NCT01787669 Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01787669 Completed University of Sydney 2017-01-31
NCT01774474 PRevention of Macular EDema After Cataract Surgery https://ClinicalTrials.gov/show/NCT01774474 Completed Maastricht University Medical Center 2016-11-04
NCT03511898 A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03511898 Completed Oxurion 2019-05-22
NCT01732614 Topcon Endpoint Management https://ClinicalTrials.gov/show/NCT01732614 Completed Retinal Consultants of Arizona 2013-11-30
NCT01702441 Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01702441 Completed Aerpio Therapeutics 2013-09-30
NCT01698749 Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698749 Completed Postgraduate Institute of Medical Education and Research 2012-01-31
NCT01684202 A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) https://ClinicalTrials.gov/show/NCT01684202 Completed Otsuka Pharmaceutical Co., Ltd. 2013-12-31
NCT01662518 DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01662518 Completed Centro de Pesquisa Rubens Siqueira 2016-01-31
NCT01661946 Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye https://ClinicalTrials.gov/show/NCT01661946 Completed Queen’s University 2013-07-31
NCT01660802 Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01660802 Completed Allergan 2014-03-31
NCT03927690 Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03927690 Recruiting Novartis 2021-02-09
NCT01618448 Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure https://ClinicalTrials.gov/show/NCT01618448 Completed Taiwan Otsuka Pharm. Co., Ltd 2014-05-31
NCT01610557 Ranibizumab and Bevacizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01610557 Completed National Institutes of Health Clinical Center (CC) 2015-02-28
NCT00799227 Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00799227 Completed Allergan 2009-12-01
NCT02556424 Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema https://ClinicalTrials.gov/show/NCT02556424 Recruiting Nantes University Hospital 2020-10-31
NCT01571232 Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01571232 Completed Retina Macula Institute 2014-02-28
NCT01564108 The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema https://ClinicalTrials.gov/show/NCT01564108 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-06-30
NCT01546402 Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01546402 Completed Postgraduate Institute of Medical Education and Research 2012-11-30
NCT01535261 Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01535261 Completed Novartis 2015-03-31
NCT01518907 The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) https://ClinicalTrials.gov/show/NCT01518907 Completed Endo Pharmaceuticals 2012-12-31
NCT01512966 Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) https://ClinicalTrials.gov/show/NCT01512966 Completed Bayer 2013-09-30
NCT01512901 Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) https://ClinicalTrials.gov/show/NCT01512901 Completed Santen Pharmaceutical Co., Ltd. NA
NCT01492400 Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01492400 Completed Allergan 2014-02-13
NCT01476449 Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema https://ClinicalTrials.gov/show/NCT01476449 Completed Retina Vitreous Associates of Florida 2016-09-30
NCT01473251 Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration https://ClinicalTrials.gov/show/NCT01473251 Completed Vitreo-Retinal Associates, Michigan 2014-04-30
NCT01445899 PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01445899 Completed Quark Pharmaceuticals 2013-11-30
NCT01442064 An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) https://ClinicalTrials.gov/show/NCT01442064 Completed Genentech, Inc. 2010-07-31
NCT01441102 Dextromethorphan for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01441102 Completed National Institutes of Health Clinical Center (CC) 2014-06-30
NCT01428388 Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion https://ClinicalTrials.gov/show/NCT01428388 Completed Barnes Retina Institute 2015-10-31
NCT01411254 Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) https://ClinicalTrials.gov/show/NCT01411254 Completed Santen Pharmaceutical Co., Ltd. NA
NCT01396083 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01396083 Completed Novartis 2014-01-31
NCT01396057 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) https://ClinicalTrials.gov/show/NCT01396057 Completed Novartis 2013-06-30
NCT01395069 Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01395069 Completed Queen’s University 2011-05-31
NCT01389089 Effective Treatment of Posttraumatic and Postoperative Edema https://ClinicalTrials.gov/show/NCT01389089 Completed Luzerner Kantonsspital 2009-01-31
NCT01363440 Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01363440 Completed Regeneron Pharmaceuticals 2013-01-31
NCT01355692 Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01355692 Completed Lumenis Ltd. 2015-06-30
NCT01342159 Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01342159 Completed Hallym University Medical Center 2010-02-28
NCT01331681 Intravitreal Aflibercept Injection in Vision Impairment Due to DME https://ClinicalTrials.gov/show/NCT01331681 Completed Bayer 2013-06-30
NCT01331005 NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01331005 Completed Jaeb Center for Health Research 2013-12-31
NCT03699046 Evaluating the Effectiveness of Subchondroplasty for Treating Bone Marrow Lesions of the Knee https://ClinicalTrials.gov/show/NCT03699046 Recruiting University of Calgary 2021-03-31
NCT01324869 Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01324869 Completed Chengdu Kanghong Biotech Co., Ltd. 2012-02-29
NCT01319487 Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01319487 Completed Fovea Pharmaceuticals SA 2012-03-31
NCT04418427 ADVM-022 Intravitreal Gene Therapy for DME https://ClinicalTrials.gov/show/NCT04418427 Recruiting Adverum Biotechnologies, Inc. 2021-05-31
NCT04411693 Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04411693 Recruiting The Cleveland Clinic 2021-06-01
NCT04359771 Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04359771 Completed Cairo University 2018-09-25
NCT04332133 Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04332133 Completed Minia University 2019-03-31
NCT04296838 Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF https://ClinicalTrials.gov/show/NCT04296838 Recruiting Peking Union Medical College Hospital 2020-05-31
NCT04215692 Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients https://ClinicalTrials.gov/show/NCT04215692 Recruiting Instituto Mexicano del Seguro Social 2020-06-01
NCT04191629 Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema https://ClinicalTrials.gov/show/NCT04191629 Recruiting Asociación para Evitar la Ceguera en México 2020-12-31
NCT04187443 MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema https://ClinicalTrials.gov/show/NCT04187443 Recruiting MingSight Pharmaceuticals Pty Limited 2021-08-18
NCT04164927 The Effects of Manual Lymphatic Drainage and Kinesiotaping on Lower Extremity Edema https://ClinicalTrials.gov/show/NCT04164927 Completed Hacettepe University 2015-08-30
NCT04151407 The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT04151407 Recruiting Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 2020-12-31
NCT04148950 Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease https://ClinicalTrials.gov/show/NCT04148950 Completed Istanbul University 2015-05-31
NCT04125394 Efficacy and Tolerance of Hypertonic Sodium Chloride (NaCl 5%) Eye Drops Without Preservatives in Corneal Edema https://ClinicalTrials.gov/show/NCT04125394 Recruiting Tiedra Farmacéutica SL 2020-05-31
NCT04120636 Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120636 Recruiting Targeted Therapy Technologies, LLC 2020-10-30
NCT04120311 Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120311 Recruiting Targeted Therapy Technologies, LLC 2020-08-25
NCT04119297 Effects of Cold Application and Heparinoid on Periorbital Edema and Ecchymosis https://ClinicalTrials.gov/show/NCT04119297 Completed Necmettin Erbakan University 2011-07-01
NCT04108156 This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab https://ClinicalTrials.gov/show/NCT04108156 Recruiting Hoffmann-La Roche 2021-10-31
NCT04089605 Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04089605 Completed Far Eastern Memorial Hospital 2018-11-01
NCT04088630 Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage https://ClinicalTrials.gov/show/NCT04088630 Recruiting Wake Forest University Health Sciences 2022-04-30
NCT04087746 Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT04087746 Completed Minia University 2019-01-31
NCT04085341 A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT04085341 Active, not recruiting Graybug Vision 2020-04-30
NCT04063358 Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT04063358 Recruiting Second Military Medical University 2021-08-31
NCT02699450 A Study of Faricimab (RO6867461) in Participants With Center-involving Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02699450 Completed Hoffmann-La Roche 2017-09-15
NCT04014556 Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04014556 Completed University of Alexandria 2018-10-01
NCT04014088 Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP) https://ClinicalTrials.gov/show/NCT04014088 Completed Hospital Raja Permaisuri Bainun 2017-12-31
NCT04005430 A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT04005430 Recruiting Targeted Therapy Technologies, LLC 2020-06-15
NCT04005092 Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT04005092 Completed Hospital Raja Permaisuri Bainun 2018-08-31
NCT03984110 The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial) https://ClinicalTrials.gov/show/NCT03984110 Recruiting Texas Retina Associates 2020-06-15
NCT03975088 Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03975088 Completed University of Alexandria 2017-12-31
NCT03974425 One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab https://ClinicalTrials.gov/show/NCT03974425 Completed University of Alexandria 2017-04-01
NCT03956797 Long Term Safety of Cooling Anesthesia for Intravitreal Injection https://ClinicalTrials.gov/show/NCT03956797 Recruiting Recens Medical, Inc. 2020-05-30
NCT03953807 A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated https://ClinicalTrials.gov/show/NCT03953807 Recruiting Allergan 2021-05-31
NCT03936751 Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY. https://ClinicalTrials.gov/show/NCT03936751 Recruiting University of Sao Paulo 2020-04-01
NCT03917472 Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03917472 Active, not recruiting Novartis 2021-07-30
NCT03908723 Treatment of Macular Edema Caused by Leber’s Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation https://ClinicalTrials.gov/show/NCT03908723 Recruiting Alexandria University 2021-03-29
NCT03867305 Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled https://ClinicalTrials.gov/show/NCT03867305 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-07-31
NCT03866746 Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866746 Completed Al Hadi Hospital 2017-06-21
NCT03866473 A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866473 Active, not recruiting Jaeb Center for Health Research 2020-04-21
NCT03835884 A Study Assessing AR-13503 Implant Alone and in Combination With Aflibercept in Subjects With nAMD or DME https://ClinicalTrials.gov/show/NCT03835884 Active, not recruiting Aerie Pharmaceuticals 2021-09-30
NCT03832179 Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification https://ClinicalTrials.gov/show/NCT03832179 Recruiting Bay Area Retina Associates 2020-06-01
NCT01698788 Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698788 Completed Postgraduate Institute of Medical Education and Research 2011-12-31
NCT03759860 Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03759860 Active, not recruiting LUTRONIC Corporation 2019-07-30
NCT03739593 Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT03739593 Active, not recruiting Aerie Pharmaceuticals 2020-05-31
NCT02368366 Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI https://ClinicalTrials.gov/show/NCT02368366 Completed Children’s Hospital Medical Center, Cincinnati 2017-11-30
NCT03715387 Tacrolimus for Malar Edema https://ClinicalTrials.gov/show/NCT03715387 Recruiting University of British Columbia 2019-07-01
NCT03690167 Investigation of the Effects of CGF and A-PRF on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery https://ClinicalTrials.gov/show/NCT03690167 Completed T.C. ORDU ÜNİVERSİTESİ 2019-03-01
NCT03675685 Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP https://ClinicalTrials.gov/show/NCT03675685 Completed Endo Pharmaceuticals 2018-11-01
NCT03666923 A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03666923 Completed Oxurion 2019-11-20
NCT03660345 Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03660345 Recruiting Rush Eye Associates 2020-09-04
NCT03641144 Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03641144 Recruiting Sun Yat-sen University 2019-07-31
NCT03635814 The Study to YD312 Tablet in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03635814 Active, not recruiting YD Global Life Science Co., Ltd. 2018-07-27
NCT03632993 Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) https://ClinicalTrials.gov/show/NCT03632993 Completed Endo Pharmaceuticals 2019-01-24
NCT03622593 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03622593 Enrolling by invitation Hoffmann-La Roche 2020-09-30
NCT03622580 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) https://ClinicalTrials.gov/show/NCT03622580 Active, not recruiting Hoffmann-La Roche 2020-09-30
NCT02302079 A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02302079 Completed Astellas Pharma Inc 2016-08-12
NCT03590444 Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser https://ClinicalTrials.gov/show/NCT03590444 Completed Hospital Hietzing 2018-04-02
NCT03546725 The Effect of Compression Stockings on Edema and Discomfort During Short Haul Flights https://ClinicalTrials.gov/show/NCT03546725 Completed Herlev and Gentofte Hospital 2018-05-26
NCT03533478 Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema https://ClinicalTrials.gov/show/NCT03533478 Completed Catalysis SL 2018-12-01
NCT03526549 Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite) https://ClinicalTrials.gov/show/NCT03526549 Active, not recruiting Endo Pharmaceuticals 2023-10-31
NCT03519581 Micropulse for Suppression of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03519581 Recruiting University of California, Davis 2020-12-31
NCT03499223 A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03499223 Completed Oxurion 2019-07-18
NCT03495765 To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03495765 Completed Marsden Eye Specialists 2017-01-01
NCT03490409 Effect of Compression Therapy on Postoperative Swelling and Pain After Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT03490409 Completed Naestved Hospital 2018-04-09
NCT03481660 A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481660 Active, not recruiting Novartis 2020-07-15
NCT03481634 Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481634 Active, not recruiting Novartis 2020-11-11
NCT03466099 Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) https://ClinicalTrials.gov/show/NCT03466099 Completed KalVista Pharmaceuticals, Ltd. 2019-10-10
NCT03453281 Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection https://ClinicalTrials.gov/show/NCT03453281 Completed Indonesia University 2018-04-09
NCT03446781 Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women https://ClinicalTrials.gov/show/NCT03446781 Completed Endo Pharmaceuticals 2018-09-26
NCT03438864 Acute Effects of Interferential Current on Edema, Pain and Muscle Strength in Patients With Distal Radius Fracture https://ClinicalTrials.gov/show/NCT03438864 Completed Ege University 2017-12-07
NCT03428750 Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women https://ClinicalTrials.gov/show/NCT03428750 Completed Endo Pharmaceuticals 2018-09-26
NCT03412760 Hydrops: Diagnosing & Redefining Outcomes With Precision Study https://ClinicalTrials.gov/show/NCT03412760 Recruiting University of California, San Francisco 2025-11-30
NCT01259609 Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy https://ClinicalTrials.gov/show/NCT01259609 Completed Seoul National University Hospital 2010-04-30
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment https://ClinicalTrials.gov/show/NCT01257815 Completed Novartis 2013-04-30
NCT01244334 Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. https://ClinicalTrials.gov/show/NCT01244334 Completed Cincinnati Eye Institute Northern Kentucky 2010-06-30
NCT01231633 Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01231633 Completed Long Island Vitreoretinal Consultants 2014-09-30
NCT01219205 Major and Macular Branched Retinal Venous Occlusion https://ClinicalTrials.gov/show/NCT01219205 Completed Hallym University Medical Center 2009-02-28
NCT01202461 Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01202461 Completed Samsung Medical Center 2010-08-31
NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01189461 Completed Pfizer 2012-07-31
NCT01171976 Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01171976 Completed Novartis 2013-04-30
NCT01208948 Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01208948 Completed Ludwig-Maximilians - University of Munich 2005-04-30
NCT01175070 Intravitreal Macugen for Ischaemic Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01175070 Completed University of Oxford 2013-03-31
NCT01135914 Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01135914 Completed Novartis 2013-03-31
NCT01112085 MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) https://ClinicalTrials.gov/show/NCT01112085 Completed Especialistas en Retina Medica y Quirurgica Grupo de Investigacion 2014-01-31
NCT01100307 A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01100307 Completed Pfizer 2012-08-31
NCT01077401 Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study https://ClinicalTrials.gov/show/NCT01077401 Completed Johns Hopkins University 2012-03-31
NCT01060969 Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention https://ClinicalTrials.gov/show/NCT01060969 Completed Sheba Medical Center 2010-08-31
NCT01030601 Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) https://ClinicalTrials.gov/show/NCT01030601 Completed University Health Network, Toronto 2011-01-31
NCT01027650 Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01027650 Completed Allergan 2012-04-30
NCT00997191 Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) https://ClinicalTrials.gov/show/NCT00997191 Completed University of Sao Paulo 2011-11-30
NCT00994955 Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00994955 Completed University of Schleswig-Holstein 2008-12-31
NCT00989989 Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00989989 Completed Novartis 2011-08-31
NCT00943072 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT00943072 Completed Regeneron Pharmaceuticals 2010-10-31
NCT00912158 Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT00912158 Completed Assiut University 2007-11-30
NCT00900887 Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema https://ClinicalTrials.gov/show/NCT00900887 Completed Hospital Juarez de Mexico 2015-03-31
NCT00886808 Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00886808 Completed iCo Therapeutics Inc. 2010-05-31
NCT00874744 Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00874744 Completed Universidade Federal de Goias 2008-09-30
NCT00846092 Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study https://ClinicalTrials.gov/show/NCT00846092 Completed Medical College of Wisconsin 2013-02-28
NCT04234438 Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser https://ClinicalTrials.gov/show/NCT04234438 Completed Ankara Universitesi Teknokent 2019-10-30
NCT03821168 The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03821168 Recruiting Shahid Beheshti University of Medical Sciences 2019-04-01
NCT02181400 Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02181400 Completed University of Sydney 2019-02-15
NCT01769352 Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1) https://ClinicalTrials.gov/show/NCT01769352 Completed Johns Hopkins University 2016-04-30
NCT01694212 Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01694212 Completed Eye Clinic Medic Zuljan Jukic 2016-10-31
NCT00970957 Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00970957 Completed Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 2013-02-28
NCT00826618 Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00826618 Completed University of Miami 2012-09-30
NCT00901186 Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00901186 Completed Novartis 2012-08-31
NCT03908307 Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China https://ClinicalTrials.gov/show/NCT03908307 Recruiting Allergan 2021-09-30
NCT03598205 Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03598205 Completed Fondazione G.B. Bietti, IRCCS 2018-09-28
NCT01783886 Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement https://ClinicalTrials.gov/show/NCT01783886 Completed Bayer 2015-03-31
NCT01552408 Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) https://ClinicalTrials.gov/show/NCT01552408 Completed Greater Houston Retina Research 2017-05-18
NCT01273727 Ozurdex for Macular Edema Post Membrane Peeling https://ClinicalTrials.gov/show/NCT01273727 Completed Retina Specialists, PC 2014-04-30
NCT00815646 Prevention and Treatment of Immersion Pulmonary Edema https://ClinicalTrials.gov/show/NCT00815646 Completed Duke University 2015-12-31
NCT00815360 Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion https://ClinicalTrials.gov/show/NCT00815360 Completed Retina Associates of Florida, P.A. 2011-07-31
NCT01945866 Phase II Combination Steroid and Anti-VEGF for Persistent DME https://ClinicalTrials.gov/show/NCT01945866 Completed Jaeb Center for Health Research 2017-06-05
NCT01846299 To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema https://ClinicalTrials.gov/show/NCT01846299 Completed Novartis 2015-09-30
NCT03690050 A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. https://ClinicalTrials.gov/show/NCT03690050 Recruiting Belfast Health and Social Care Trust 2020-12-31
NCT00801866 Avastin for Post-Photocoagulation Macular Edema https://ClinicalTrials.gov/show/NCT00801866 Completed Asociación para Evitar la Ceguera en México NA
NCT02581995 Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. https://ClinicalTrials.gov/show/NCT02581995 Completed Bayer 2017-08-09
NCT03866005 Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866005 Recruiting ZeaVision, LLC 2021-11-01
NCT02460874 Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) https://ClinicalTrials.gov/show/NCT02460874 Recruiting University of Alabama at Birmingham 2021-03-31
NCT01951066 Diabetic Macular Edema Treated With Ozurdex (DMEO) https://ClinicalTrials.gov/show/NCT01951066 Completed Johns Hopkins University 2015-12-31
NCT01471691 Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab https://ClinicalTrials.gov/show/NCT01471691 Completed Hanscom, Thomas, M.D. 2014-02-28
NCT03941977 Treatment of Bone Marrow Edema Lesions of the Knee With Percutaneous Grafting https://ClinicalTrials.gov/show/NCT03941977 Completed University of Sao Paulo General Hospital 2018-12-30
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03610646 Recruiting Mylan Inc. 2020-02-28
NCT00915837 Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00915837 Completed SurModics, Inc. 2009-04-30
NCT00785174 Non-Invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema: a Multicentre Study https://ClinicalTrials.gov/show/NCT00785174 Completed University of Monastir 2008-06-30
NCT00790803 Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00790803 Completed Wake Forest University Health Sciences 2011-11-30
NCT00780780 Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00780780 Completed Federal University of São Paulo 2008-08-31
NCT00764244 Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00764244 Completed Assistance Publique - Hôpitaux de Paris 2009-12-31
NCT00758628 Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. https://ClinicalTrials.gov/show/NCT00758628 Completed Bp Consulting, Inc 2009-05-31
NCT00737971 Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00737971 Completed Federal University of São Paulo 2012-12-31
NCT00732719 Compression Device Safety Study on Edema https://ClinicalTrials.gov/show/NCT00732719 Completed ConvaTec Inc. 2004-11-30
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema https://ClinicalTrials.gov/show/NCT00683176 Completed Abbott 2011-03-31
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study https://ClinicalTrials.gov/show/NCT00687804 Completed Novartis 2010-01-31
NCT00687154 Observational Study of DME Following Scatter Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00687154 Completed Jaeb Center for Health Research 2008-01-31
NCT00682539 Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00682539 Completed Medical University of Vienna 2014-07-31
NCT00665106 Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00665106 Completed Santen SAS 2011-09-30
NCT00656643 Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00656643 Completed Santen Inc. 2009-11-30
NCT00627770 Lower Leg Edema Evaluation After Total Knee Arthroplasty Using Bioimpedance https://ClinicalTrials.gov/show/NCT00627770 Completed Haute Ecole de Santé Vaud 2008-11-30
NCT00605280 A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. https://ClinicalTrials.gov/show/NCT00605280 Completed Pfizer 2009-11-30
NCT00604227 Pulmonary Function at High-Altitude https://ClinicalTrials.gov/show/NCT00604227 Completed Heidelberg University NA
NCT00595543 Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% https://ClinicalTrials.gov/show/NCT00595543 Completed Bp Consulting, Inc 2009-03-31
NCT00593190 Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus https://ClinicalTrials.gov/show/NCT00593190 Completed HaEmek Medical Center, Israel 2008-12-31
NCT00562406 Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) https://ClinicalTrials.gov/show/NCT00562406 Completed Klinikum Ludwigshafen 2010-09-30
NCT00576459 Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00576459 Completed Bausch & Lomb Incorporated 2006-06-30
NCT00567697 A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO https://ClinicalTrials.gov/show/NCT00567697 Completed Aleris Helse 2008-10-31
NCT00559442 Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction https://ClinicalTrials.gov/show/NCT00559442 Completed Heidelberg University 2010-12-31
NCT00554580 Continuous Positive Airway Pressure for Acute Pulmonary Edema https://ClinicalTrials.gov/show/NCT00554580 Completed Assistance Publique - Hôpitaux de Paris 2008-07-31
NCT00544869 A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure) https://ClinicalTrials.gov/show/NCT00544869 Completed Otsuka Pharmaceutical Co., Ltd. 2009-02-28
NCT00536692 Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT00536692 Completed CoMentis NA
NCT00525265 A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) https://ClinicalTrials.gov/show/NCT00525265 Completed Otsuka Pharmaceutical Co., Ltd. 2009-01-31
NCT00502541 Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00502541 Completed Bausch & Lomb Incorporated 2006-09-30
NCT00498355 Lucentis for Inflammatory Macular Edema Trial https://ClinicalTrials.gov/show/NCT00498355 Completed University of California, San Francisco 2009-01-31
NCT00496405 Unilateral Bevacizumab for Bilateral Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00496405 Completed Asociación para Evitar la Ceguera en México NA
NCT00494494 Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery https://ClinicalTrials.gov/show/NCT00494494 Completed University of North Carolina, Chapel Hill 2008-04-30
NCT00490815 Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00490815 Completed Alimera Sciences 2009-09-30
NCT00486018 A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) https://ClinicalTrials.gov/show/NCT00486018 Completed Genentech, Inc. 2009-05-31
NCT00485836 A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) https://ClinicalTrials.gov/show/NCT00485836 Completed Genentech, Inc. 2009-06-30
NCT00473382 A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) https://ClinicalTrials.gov/show/NCT00473382 Completed Genentech, Inc. 2011-01-31
NCT00473330 A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) https://ClinicalTrials.gov/show/NCT00473330 Completed Genentech, Inc. 2010-11-30
NCT00469781 Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening https://ClinicalTrials.gov/show/NCT00469781 Completed Center For Excellence In Eye Care 2008-09-30
NCT00464685 Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00464685 Completed Allergan 2010-02-08
NCT00462670 A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) https://ClinicalTrials.gov/show/NCT00462670 Completed Otsuka Pharmaceutical Co., Ltd. 2008-10-31
NCT00453947 Non-Invasive Ventilation in Pulmonary Edema https://ClinicalTrials.gov/show/NCT00453947 Completed Ospedale S. Giovanni Bosco NA
NCT00446381 Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) https://ClinicalTrials.gov/show/NCT00446381 Completed Lawson Health Research Institute 2008-09-30
NCT00444600 Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00444600 Completed Jaeb Center for Health Research 2009-12-31
NCT00440609 Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00440609 Completed Long Island Vitreoretinal Consultants 2012-11-30
NCT00412451 A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT00412451 Completed ThromboGenics 2010-01-31
NCT00407381 The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study https://ClinicalTrials.gov/show/NCT00407381 Completed Johns Hopkins University 2010-08-31
NCT00407355 Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions https://ClinicalTrials.gov/show/NCT00407355 Completed Johns Hopkins University 2013-02-28
NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00401115 Completed Santen Inc. 2008-06-30
NCT00390442 Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT00390442 Completed Hopital Lariboisière NA
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00387582 Completed Rocky Mountain Retina Consultants 2009-02-28
NCT00371410 Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00371410 Completed Samsung Medical Center NA
NCT00369863 A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00369863 Completed Shahid Beheshti University of Medical Sciences NA
NCT00369486 A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00369486 Completed Jaeb Center for Health Research 2006-06-30
NCT00367133 Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00367133 Completed Jaeb Center for Health Research 2008-05-31
NCT00346138 A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema https://ClinicalTrials.gov/show/NCT00346138 Completed Mayo Clinic 2009-06-30
NCT00344968 Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00344968 Completed Alimera Sciences 2009-12-31
NCT00333671 Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) https://ClinicalTrials.gov/show/NCT00333671 Completed Glostrup University Hospital, Copenhagen 2006-02-28
NCT00320814 Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00320814 Completed Regeneron Pharmaceuticals 2006-08-31
NCT00308542 A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00308542 Completed Sanwa Kagaku Kenkyusho Co., Ltd. NA
NCT00308477 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00308477 Completed Sanwa Kagaku Kenkyusho Co., Ltd. NA
NCT00306904 Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00306904 Completed OPKO Health, Inc. 2007-09-30
NCT00284050 Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement https://ClinicalTrials.gov/show/NCT00284050 Completed Novartis 2008-06-30
NCT00280826 Efalizumab to Treat Uveitis https://ClinicalTrials.gov/show/NCT00280826 Completed National Institutes of Health Clinical Center (CC) 2009-02-28
NCT00274430 Prevention of High Altitude Pulmonary Edema https://ClinicalTrials.gov/show/NCT00274430 Completed University of Zurich NA
NCT00234104 A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure) https://ClinicalTrials.gov/show/NCT00234104 Completed Otsuka Pharmaceutical Co., Ltd. 2006-01-31
NCT00229931 Triamcinolone vs. Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00229931 Completed University of Oklahoma 2013-05-31
NCT00213681 CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT00213681 Completed University Hospital, Rouen NA
NCT00167518 Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) https://ClinicalTrials.gov/show/NCT00167518 Completed University of Sydney NA
NCT00199576 Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids https://ClinicalTrials.gov/show/NCT00199576 Completed University Hospital, Limoges NA
NCT00168389 A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00168389 Completed Allergan 2012-06-30
NCT00168324 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00168324 Completed Allergan 2008-03-01
NCT00168298 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00168298 Completed Allergan 2008-03-01
NCT00168337 A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00168337 Completed Allergan 2012-05-31
NCT00133952 Effect of Ruboxistaurin on Clinically Significant Macular Edema https://ClinicalTrials.gov/show/NCT00133952 Completed Chromaderm, Inc. 2011-07-31
NCT00148330 Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study https://ClinicalTrials.gov/show/NCT00148330 Completed University of Sydney 2008-07-31
NCT00148265 A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT00148265 Completed University of Sydney 2009-05-31
NCT00105027 The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study https://ClinicalTrials.gov/show/NCT00105027 Completed The Emmes Company, LLC 2009-02-28
NCT00137228 Measuring Hand Edema in Burn Patients https://ClinicalTrials.gov/show/NCT00137228 Completed United States Army Institute of Surgical Research NA
NCT00106132 Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage https://ClinicalTrials.gov/show/NCT00106132 Completed National Institutes of Health Clinical Center (CC) NA
NCT00105404 Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00105404 Completed National Institutes of Health Clinical Center (CC) NA
NCT00088166 XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors https://ClinicalTrials.gov/show/NCT00088166 Completed Celtic Pharma Development Services 2008-03-31
NCT00055042 Laser and Antioxidant Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00055042 Completed National Institutes of Health Clinical Center (CC) NA
NCT00027287 Laser and Medical Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00027287 Completed National Institutes of Health Clinical Center (CC) NA
NCT00035906 Research Study in Patients With Persistent Macular Edema https://ClinicalTrials.gov/show/NCT00035906 Completed Allergan 2004-08-31
NCT00021645 Vitamin E to Treat Uveitis-Associated Macular Edema https://ClinicalTrials.gov/show/NCT00021645 Completed National Institutes of Health Clinical Center (CC) NA
NCT00071773 A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00071773 Completed Jaeb Center for Health Research 2005-11-30
NCT00532220 Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial https://ClinicalTrials.gov/show/NCT00532220 Completed University Hospital, Basel, Switzerland 2015-08-31
NCT00000115 Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00000115 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02181530 Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® https://ClinicalTrials.gov/show/NCT02181530 Completed Allergan 2014-10-31
NCT01571557 A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01571557 Completed Allergan 2014-03-31
NCT03965078 Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery https://ClinicalTrials.gov/show/NCT03965078 Recruiting Portsmouth Hospitals NHS Trust 2020-11-30
NCT03297684 Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection https://ClinicalTrials.gov/show/NCT03297684 Recruiting Advanced Eye Research Associates 2020-12-31
NCT03296085 Bedside Evaluation of Edema https://ClinicalTrials.gov/show/NCT03296085 Recruiting Geisinger Clinic 2020-12-31
NCT03154593 Prevalence of Chronic Oedema in Obese Patients https://ClinicalTrials.gov/show/NCT03154593 Completed University of Nottingham 2018-07-31
NCT03117686 Lung Ultrasound in High Altitude Lung Edema https://ClinicalTrials.gov/show/NCT03117686 Completed Medical University of Vienna 2017-06-22
NCT01621893 Evaluation of Subchondroplastyâ„¢ for Defects Associated With Bone Marrow Lesions https://ClinicalTrials.gov/show/NCT01621893 Active, not recruiting Zimmer Biomet 2018-01-17
NCT03003416 Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03003416 Completed Allergan 2018-12-19
NCT02993601 Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure https://ClinicalTrials.gov/show/NCT02993601 Completed Heartfelt Technologies 2017-06-13
NCT02979665 Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02979665 Completed Lawson Health Research Institute 2017-08-31
NCT02956330 Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 https://ClinicalTrials.gov/show/NCT02956330 Completed Clearside Biomedical, Inc. 2017-04-12
NCT02937441 Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis https://ClinicalTrials.gov/show/NCT02937441 Completed Cukurova University 2017-03-31
NCT02914808 Oedema Study : Chroedem https://ClinicalTrials.gov/show/NCT02914808 Recruiting University Hospital, Montpellier 2021-08-31
NCT02876393 A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02876393 Completed Queen’s University, Belfast 2017-01-31
NCT02874859 Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02874859 Recruiting Lille Catholic University 2019-12-31
NCT02731911 Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study https://ClinicalTrials.gov/show/NCT02731911 Completed Allergan 2018-10-22
NCT02661269 Relation Between the Increase of Peripheral Edema by Fluid Therapy and the Decrease in Microcirculatory Vesseldensity https://ClinicalTrials.gov/show/NCT02661269 Completed Medical Centre Leeuwarden 2018-02-15
NCT02655094 Unilateral Pulmonary Edema After Minimal-invasive Mitral Valve Surgery https://ClinicalTrials.gov/show/NCT02655094 Completed University of Schleswig-Holstein 2016-10-31
NCT02639507 International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients https://ClinicalTrials.gov/show/NCT02639507 Completed Mayo Clinic 2020-03-31
NCT02637245 Imaging Parameters and DME Treatment Response https://ClinicalTrials.gov/show/NCT02637245 Recruiting Duke University 2020-05-31
NCT02623673 Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT02623673 Completed Retina Clinic, Sao Paulo, Brazil 2015-12-31
NCT03394573 Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study) https://ClinicalTrials.gov/show/NCT03394573 Recruiting University Hospital Inselspital, Berne 2021-09-30
NCT02329132 Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02329132 Completed Kagawa University 2018-01-28
NCT03385382 Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03385382 Completed G. d’Annunzio University 2017-06-27
NCT02217306 Contrast Sensitivity and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02217306 Completed Hospital Juarez de Mexico 2014-07-31
NCT02188173 An Observational Study of OZURDEX® in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02188173 Completed Allergan 2016-05-31
NCT02121197 Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema. https://ClinicalTrials.gov/show/NCT02121197 Completed Association for Innovation and Biomedical Research on Light and Image 2016-01-31
NCT02088229 Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02088229 Completed University of Michigan 2015-06-30
NCT01314469 Quality of Life in Patients With Intermediate Uveitis https://ClinicalTrials.gov/show/NCT01314469 Completed St. Franziskus Hospital NA
NCT01299129 Functional and Morphologic Aspects of Intravitreal Triamcinolone for Uveitis-associated Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT01299129 Completed Medical University of Vienna 2011-06-30
NCT02000102 Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab https://ClinicalTrials.gov/show/NCT02000102 Completed Stanford University 2014-09-30
NCT01998568 The Intraocular Pressure Measured by Different Tonometers in Corneal Edema https://ClinicalTrials.gov/show/NCT01998568 Completed Prince of Songkla University 2016-06-30
NCT01947881 Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES) https://ClinicalTrials.gov/show/NCT01947881 Completed Association for Innovation and Biomedical Research on Light and Image 2015-02-28
NCT01934920 Identifying Patients With Unrecognized Treatable Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01934920 Recruiting Elman Retina Group 2019-05-31
NCT01918371 A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01918371 Completed Allergan 2014-09-04
NCT01876914 Pilot Study of OCT Versus Fluorescein Angiography in DME https://ClinicalTrials.gov/show/NCT01876914 Completed Oregon Health and Science University 2017-12-23
NCT01805323 A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema https://ClinicalTrials.gov/show/NCT01805323 Completed Allergan 2013-04-15
NCT01794130 The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude https://ClinicalTrials.gov/show/NCT01794130 Completed Institute of Mountain Emergency Medicine 2011-07-31
NCT01771081 Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy https://ClinicalTrials.gov/show/NCT01771081 Completed Bayer 2015-01-31
NCT01681927 Study of Idiopathic Edema https://ClinicalTrials.gov/show/NCT01681927 Completed Winthrop University Hospital 2016-11-30
NCT01618266 Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01618266 Completed Allergan 2013-04-30
NCT01566526 Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01566526 Completed Allergan 2012-06-30
NCT01455766 Volumetric Monitoring in Major Lung Surgery https://ClinicalTrials.gov/show/NCT01455766 Completed Northern State Medical University 2008-02-29
NCT01445626 A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01445626 Completed Allergan 2012-01-31
NCT01358396 Glycemic Control and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01358396 Completed Cairo University 2010-07-31
NCT04387604 Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04387604 Completed Centro Hospitalar do Porto 2018-02-01
NCT04381117 Long-term Durability Study of CCH https://ClinicalTrials.gov/show/NCT04381117 Enrolling by invitation Endo Pharmaceuticals 2020-06-30
NCT04151160 Point of Care Ultrasound Measurements of Perioperative Edema in Infants With Congenital Heart Disease https://ClinicalTrials.gov/show/NCT04151160 Recruiting University of Colorado, Denver 2021-02-28
NCT04140448 Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT04140448 Recruiting Renmin Hospital of Wuhan University 2021-10-30
NCT04072744 Foot Oedema Observed Over Time Study https://ClinicalTrials.gov/show/NCT04072744 Recruiting Heartfelt Technologies 2022-03-14
NCT04018833 Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04018833 Completed Centro Hospitalar do Porto 2016-06-01
NCT03999138 MRI Assessment of Pulmonary Edema in Acute Heart Failure https://ClinicalTrials.gov/show/NCT03999138 Recruiting University of Alberta 2024-06-01
NCT03911531 Whole Exome Sequencing and Whole Genome Sequencing for Non-immune Fetal/Neonatal Hydrops https://ClinicalTrials.gov/show/NCT03911531 Recruiting Thomas Jefferson University 2021-06-30
NCT03893890 Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women https://ClinicalTrials.gov/show/NCT03893890 Completed Endo Pharmaceuticals 2019-06-25
NCT03889444 Chart Review: Drug Utilization Study in Participants Who Received Ozurdexâ„¢ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03889444 Completed Allergan 2019-06-07
NCT03883555 High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency Department https://ClinicalTrials.gov/show/NCT03883555 Completed University Hospital, Montpellier 2016-09-01
NCT03768752 Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients https://ClinicalTrials.gov/show/NCT03768752 Active, not recruiting Universitätsklinikum Hamburg-Eppendorf 2020-11-01
NCT03703284 Molecular Mechanisms of Malignant Cerebral Edema After LHI https://ClinicalTrials.gov/show/NCT03703284 Recruiting Xuanwu Hospital, Beijing 2022-12-31
NCT03597815 Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study https://ClinicalTrials.gov/show/NCT03597815 Active, not recruiting Uptown Eye Specialists 2018-12-31
NCT03596931 Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients https://ClinicalTrials.gov/show/NCT03596931 Completed Faculty of Medicine, Tarumanagara University 2018-06-30
NCT03590587 Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates https://ClinicalTrials.gov/show/NCT03590587 Recruiting Benha University 2018-09-15
NCT03559491 Dexamethasone Intravitreal Implant in Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03559491 Completed Università degli Studi dell’Insubria 2017-10-01
NCT03494660 SCP Hip Outcomes Study https://ClinicalTrials.gov/show/NCT03494660 Recruiting Zimmer Biomet 2022-03-31
NCT01162161 Role of Sphingolipids in Pulmonary Edema https://ClinicalTrials.gov/show/NCT01162161 Completed RWTH Aachen University 2012-12-31
NCT00906659 Visual Function, Center Point Thickness and Macular Volume After Photocoagulation https://ClinicalTrials.gov/show/NCT00906659 Completed Hospital Juarez de Mexico 2007-12-31
NCT00886392 Diabetic Macular Edema Severity at Diagnosis https://ClinicalTrials.gov/show/NCT00886392 Completed Hospital Juarez de Mexico 2007-12-31
NCT00829855 Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema https://ClinicalTrials.gov/show/NCT00829855 Completed Carol Davila University of Medicine and Pharmacy 2009-05-31
NCT04057690 Automatic PredICtion of Edema After Stroke https://ClinicalTrials.gov/show/NCT04057690 Recruiting University Hospital Tuebingen 2020-03-31
NCT02933905 Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection https://ClinicalTrials.gov/show/NCT02933905 Completed Fundació Institut Germans Trias i Pujol 2015-01-31
NCT01318941 Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting https://ClinicalTrials.gov/show/NCT01318941 Completed Novartis 2016-04-30
NCT01945892 Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome https://ClinicalTrials.gov/show/NCT01945892 Completed Ludwig-Maximilians - University of Munich 2013-06-30
NCT02653365 Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema https://ClinicalTrials.gov/show/NCT02653365 Completed Beijing Chao Yang Hospital 2015-03-31
NCT02850263 A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02850263 Active, not recruiting Bayer 2019-05-30
NCT01897350 Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial https://ClinicalTrials.gov/show/NCT01897350 Completed University of Bristol 2013-12-31
NCT03783832 Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography https://ClinicalTrials.gov/show/NCT03783832 Recruiting Aquitania Opthalmologica 2019-12-31
NCT03161912 A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease https://ClinicalTrials.gov/show/NCT03161912 Recruiting Bayer 2021-08-31
NCT00791726 Microperimetry in Macular Edema https://ClinicalTrials.gov/show/NCT00791726 Completed St. Franziskus Hospital NA
NCT00691847 Reducing Edema Following Refractive Surgery https://ClinicalTrials.gov/show/NCT00691847 Completed FORSIGHT Vision3 2008-09-30
NCT00563940 Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00563940 Completed University Hospital Inselspital, Berne 2010-02-28
NCT00488956 Foot and Ankle Edema Post-Cesarean Delivery https://ClinicalTrials.gov/show/NCT00488956 Completed University of British Columbia 2007-09-30
NCT00464581 Lucentis for Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT00464581 Completed Retina Institute of Hawaii 2009-12-31
NCT00709319 Evaluation of Vitrectomy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00709319 Completed Jaeb Center for Health Research 2008-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01824862 Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01824862 Completed Hospital Juarez de Mexico 2013-06-30
NCT04311359 A Pharmacovigilance Study of Brain Oedema https://ClinicalTrials.gov/show/NCT04311359 Completed University of Peshawar 2019-11-10
NCT03762226 Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study https://ClinicalTrials.gov/show/NCT03762226 Recruiting University of Leipzig 2021-06-30